back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-28 18:05 Tx date 2025-03-24 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,200
+5,000 vol $1.84 each |
5,000 | |
| Filed 2025-03-28 18:02 Tx date 2025-03-24 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,200
-5,000 vol $1.84 each |
15,000 | |
| Filed 2025-03-06 19:03 Tx date 2025-02-28 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-180,985
-5,000 vol $36.20 each |
0 | |
| Filed 2024-12-09 16:45 Tx date 2024-10-03 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+10,000 vol $1.65 each |
||
| Filed 2024-12-09 16:44 Tx date 2024-03-22 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$36,800
+20,000 vol $1.84 each |
||
| Filed 2024-10-28 22:10 Tx date 2024-10-03 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+10,000 vol $1.65 each |
||
| Filed 2024-10-28 22:04 Tx date 2024-03-22 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$36,800
+20,000 vol $1.84 each |
||
| Filed 2024-11-13 19:43 Tx date 2024-11-12 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-653,408
-16,000 vol $40.84 each |
5,000 | |
| Filed 2024-11-08 17:18 Tx date 2024-11-05 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$100,000
+16,000 vol $6.25 each |
21,000 | |
| Filed 2024-11-08 17:17 Tx date 2024-11-05 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-16,000 vol $6.25 each |
50,000 | |
| Filed 2024-11-08 17:16 Tx date 2024-11-05 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,172
-400 vol $77.93 each |
5,000 | |
| Filed 2024-11-08 17:15 Tx date 2024-11-04 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-248,975
-5,000 vol $49.80 each |
5,400 | |
| Filed 2024-11-04 18:13 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,250
+5,000 vol $1.65 each |
10,400 | |
| Filed 2024-11-04 18:12 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,200
+5,000 vol $1.84 each |
5,400 | |
| Filed 2024-11-04 18:12 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,250
-5,000 vol $1.65 each |
66,000 | |
| Filed 2024-11-04 18:11 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,200
-5,000 vol $1.84 each |
71,000 | |
| Filed 2024-11-01 18:34 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-125,900
-2,000 vol $62.95 each |
400 | |
| Filed 2024-11-01 18:33 Tx date 2024-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-54,280
-800 vol $67.85 each |
2,400 | |
| Filed 2024-11-01 18:33 Tx date 2024-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,160
-800 vol $46.45 each |
3,200 | |
| Filed 2024-10-29 20:44 Tx date 2024-10-03 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+10,000 vol $1.65 each |
76,000 | |
| Filed 2024-10-29 20:43 Tx date 2024-03-22 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,800
+20,000 vol $1.84 each |
56,000 | |
| Filed 2024-10-28 22:10 Tx date 2024-10-03 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+10,000 vol $1.65 each |
46,000 | |
| Filed 2024-10-28 22:04 Tx date 2024-03-22 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$36,800
+20,000 vol $1.84 each |
36,000 | |
| Filed 2024-10-26 15:53 Tx date 2023-07-14 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-64,000 vol |
16,000 | |
| Filed 2024-10-26 15:51 Tx date 2023-07-14 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-16,000 vol |
4,000 | |
| Filed 2021-02-01 17:10 Tx date 2021-01-29 |
$
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2021-02-01 17:09 Tx date 2021-01-29 |
$
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 |